SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,758 | -47.0% | 3,437 | -42.2% | 0.02% | -61.5% |
| Q2 2023 | $178,797 | -16.7% | 5,948 | +0.4% | 0.05% | -24.6% |
| Q1 2023 | $214,699 | -4.8% | 5,926 | -6.2% | 0.07% | -8.0% |
| Q4 2022 | $225,470 | +77.5% | 6,321 | +68.5% | 0.08% | +19.0% |
| Q3 2022 | $127,000 | -17.5% | 3,752 | -29.6% | 0.06% | -33.7% |
| Q2 2022 | $154,000 | +40.0% | 5,327 | +56.9% | 0.10% | +72.7% |
| Q1 2022 | $110,000 | +77.4% | 3,396 | +59.1% | 0.06% | +89.7% |
| Q4 2021 | $62,000 | +5.1% | 2,135 | -2.9% | 0.03% | -23.7% |
| Q3 2021 | $59,000 | +5.4% | 2,198 | +20.0% | 0.04% | +8.6% |
| Q2 2021 | $56,000 | – | 1,832 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |